Know Cancer

or
forgot password

French National Observatory of the Patients With Non-small Cell Lung (NSCLC) Benefiting From a Molecular Test on the Hospital Platforms of Molecular Genetics.


N/A
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Non-Small-Cell Lung, TPM4-ALK Fusion Protein Expression, KRAS Gene Mutation, BRAF Gene Mutation

Thank you

Trial Information

French National Observatory of the Patients With Non-small Cell Lung (NSCLC) Benefiting From a Molecular Test on the Hospital Platforms of Molecular Genetics.


Inclusion Criteria:



- Advanced Non-small cell lung cancer (NSLC)

- Biomarkers analysis on hospital platforms

Exclusion Criteria:

-

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

EGF-R gene mutation in nationwide cohort

Outcome Description:

Number of patients with EGF-R gene mutation

Outcome Time Frame:

1 Year

Safety Issue:

No

Principal Investigator

Fabrice Barlesi, PhD, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

IFCT, Aix Marseille Université / Assistance Publique Hôpitaux de Marseille

Authority:

France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé

Study ID:

Biomarkers-France

NCT ID:

NCT01700582

Start Date:

April 2012

Completion Date:

December 2013

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • TPM4-ALK Fusion Protein Expression
  • KRAS Gene Mutation
  • BRAF Gene Mutation
  • lung cancer
  • biomarkers
  • EGFR
  • KRAS
  • ALK
  • HER2
  • PI3K
  • BRAF
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung

Name

Location